| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_241c3d4e236532a2e822eb39f56b1be9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-096 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-096 |
| filingDate |
2001-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8b3cafaea39ec329b9fd58813962394
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39a35868f22faab83bd56b929c76067c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8951d56af1a41f0a01a8bba74b1b3279 |
| publicationDate |
2002-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2002019399-A1 |
| titleOfInvention |
Therapeutic agents for drug dependence |
| abstract |
A method for preventing or treating drug dependence comprising administering to a human in need thereof a pharmaceutically effective amount of a 1,4-(diphenylalkyl)piperazine compound represented by the following formula [I] or a pharmaceutically acceptable salt thereof, wherein R 1 is lower alkoxy; R 2 is lower alkoxy; A is lower alkylene and B is lower alkylene; |
| priorityDate |
1998-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |